» Articles » PMID: 11826068

D2 Receptors Inhibit the Secretory Process Downstream from Calcium Influx in Dopaminergic Neurons: Implication of K+ Channels

Overview
Journal J Neurophysiol
Specialties Neurology
Physiology
Date 2002 Feb 5
PMID 11826068
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Dopaminergic (DAergic) neurons possess D2-like somatodendritic and terminal autoreceptors that modulate cellular excitability and dopamine (DA) release. The cellular and molecular processes underlying the rapid presynaptic inhibition of DA release by D2 receptors remain unclear. Using a culture system in which isolated DAergic neurons establish self-innervating synapses ("autapses") that release both DA and glutamate, we studied the mechanism by which presynaptic D2 receptors inhibit glutamate-mediated excitatory postsynaptic currents (EPSCs). Action-potential evoked EPSCs were reversibly inhibited by quinpirole, a selective D2 receptor agonist. This inhibition was slightly reduced by the inward rectifier K(+) channel blocker barium, largely prevented by the voltage-dependent K(+) channel blocker 4-aminopyridine, and completely blocked by their combined application. The lack of a residual inhibition of EPSCs under these conditions argues against the implication of a direct inhibition of presynaptic Ca(2+) channels. To evaluate the possibility of a direct inhibition of the secretory process, spontaneous miniature EPSCs were evoked by the Ca(2+) ionophore ionomycin. Ionomycin-evoked release was insensitive to cadmium and dramatically reduced by quinpirole, providing evidence for a direct inhibition of quantal release at a step downstream to Ca(2+) influx through voltage-dependent Ca(2+) channels. Surprisingly, this effect of quinpirole on ionomycin-evoked release was blocked by 4-aminopyridine. These results suggest that D2 receptor activation decreases neurotransmitter release from DAergic neurons through a presynaptic mechanism in which K(+) channels directly inhibit the secretory process.

Citing Articles

G protein-coupled receptor modulation of striatal dopamine transmission: Implications for psychoactive drug effects.

Littlepage-Saunders M, Hochstein M, Chang D, Johnson K Br J Pharmacol. 2023; 181(22):4399-4413.

PMID: 37258878 PMC: 10687321. DOI: 10.1111/bph.16151.


Ultra-Processed Food, Reward System and Childhood Obesity.

Calcaterra V, Cena H, Rossi V, Santero S, Bianchi A, Zuccotti G Children (Basel). 2023; 10(5).

PMID: 37238352 PMC: 10217200. DOI: 10.3390/children10050804.


Ferulic acid-loaded nanostructure prevents morphine reinstatement: the involvement of dopamine system, NRF2, and ΔFosB in the striatum brain area of rats.

Milanesi L, Rossato D, Rosa J, Davila L, Metz V, Rampelotto C Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(7):1535-1545.

PMID: 36790483 DOI: 10.1007/s00210-023-02420-w.


Implication of synaptotagmins 4 and 7 in activity-dependent somatodendritic dopamine release in the ventral midbrain.

Delignat-Lavaud B, Ducrot C, Kouwenhoven W, Feller N, Trudeau L Open Biol. 2022; 12(3):210339.

PMID: 35232250 PMC: 8889187. DOI: 10.1098/rsob.210339.


Bidirectional Regulation of Hippocampal Synaptic Plasticity and Modulation of Cumulative Spatial Memory by Dopamine D2-Like Receptors.

Caragea V, Manahan-Vaughan D Front Behav Neurosci. 2022; 15:803574.

PMID: 35095441 PMC: 8789653. DOI: 10.3389/fnbeh.2021.803574.